Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study
Keywords: درمان های مولکولی; healthy subjects; hepatic impairment; molecular therapeutics; pharmacokinetics